NORWICH PHARMACEUTICALS, INC v. ROBERT F. KENNEDY, JR
The United States Court of Appeals for the District of Columbia Circuit affirmed a district court ruling regarding the approval timeline for a generic drug application. The court held that a final judgment barring approval of a specific application number applies even if the applicant amends the application to remove infringing indications.